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The G protein-coupled receptor (GPCR) Proteolysis Site
(GPS) of cell-adhesion GPCRs and polycystic kidney
disease (PKD) proteins constitutes a highly conserved
autoproteolysis sequence, but its catalytic mechanism
remains unknown. Here, we show that unexpectedly the
B40-residue GPS motif represents an integral part of a
much larger B320-residue domain that we termed GPCR-
Autoproteolysis INducing (GAIN) domain. Crystal struc-
tures of GAIN domains from two distantly related
cell-adhesion GPCRs revealed a conserved novel fold in
which the GPS motif forms ﬁve b-strands that are tightly
integrated into the overall GAIN domain. The GAIN
domain is evolutionarily conserved from tetrahymena to
mammals, is the only extracellular domain shared by all
human cell-adhesion GPCRs and PKD proteins, and is the
locus of multiple human disease mutations. Functionally,
the GAIN domain is both necessary and sufﬁcient for
autoproteolysis, suggesting an autoproteolytic mechanism
whereby the overall GAIN domain ﬁne-tunes the chemical
environment in the GPS to catalyse peptide bond hydro-
lysis. Thus, the GAIN domain embodies a unique, evolu-
tionarily ancient and widespread autoproteolytic fold
whose function is likely relevant for GPCR signalling
and for multiple human diseases.
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Introduction
Autoproteolysis is a widely used intramolecular post-transla-
tional process that often converts inactive protein precursors
into biologically active mature proteins. For instance, the
hedgehog pathway, one of the fundamental signal transduc-
tion pathways in animal development, is activated only if the
signalling domain is cleaved off from the autoproteolytic
domain of hedgehog (Lee et al, 1994). Among autoproteolytic
domains/motifs described in various proteins (including
hedgehog, N-terminal nucleophile (Ntn) hydrolases, nucleo-
porin98, protein inteins, and pyruvoyl enzymes; Perler et al,
1997), the G protein-coupled receptor (GPCR) Proteolysis Site
(GPS) is one of the few autoproteolysis-mediating domains/
motifs found in membrane proteins. The GPS motif is con-
served in all 33 human cell-adhesion GPCRs and all 5 human
polycystic kidney disease (PKD) proteins (Krasnoperov et al,
1997; Hughes et al, 1999; Ichtchenko et al, 1999; Chang et al,
2003; Lin et al, 2004); representing one of the most wide-
spread and conserved autoproteolytic domains/motifs.
Recent studies indicate emerging physiological and patholo-
gical roles for these GPS-containing membrane proteins in
cancer (Kan et al, 2010), PKD (Qian et al, 2002), brain
development (Piao et al, 2004), myelination of neurons
(Monk et al, 2009), central nervous system angiogenesis
(Kuhnert et al, 2010), attention-deﬁcit/hyperactivity disorder
(Arcos-Burgos et al, 2010), cell polarity in neural development
(Chae et al, 1999; Usui et al, 1999; Shima et al, 2004;
Langenhan et al, 2009), Usher syndrome 2 (Ebermann et al,
2009), mouse male infertility (Davies et al, 2004), and im-
munity (see Yona et al, 2008 for a review), but the mechanism
of GPS-mediated autoproteolysis remains unclear.
Cell-adhesion GPCRs are characterized by long N-terminal
extracellular sequences comprising multiple domains, and
constitute a poorly studied class of GPCRs that is the second
largest family of GPCRs in humans (Fredriksson et al, 2003).
Most cell-adhesion GPCRs are orphan receptors with no
known ligands. They are found in animals, protozoa, and
alveolates, predating many other important signalling mole-
cules. The CIRL/Latrophilins (here abbreviated as CLs, CL1–
3) and brain angiogenesis inhibitors (BAIs, BAI1–3) are two
distant subfamilies of cell-adhesion GPCRs that both are
primarily expressed in neurons (Krasnoperov et al, 1997;
Lelianova et al, 1997; Nishimori et al, 1997; Sugita et al,
1999). CL1 is a calcium-independent receptor for a-latrotoxin,
a black widow spider toxin that triggers massive neurotrans-
mitter release from neurons and neuroendocrine cells
(Krasnoperov et al, 1997; Lelianova et al, 1997; Sugita et al,
1998; Sudhof, 2001; Deak et al, 2009). BAIs initially received
their name because an extracellular fragment of BAI1 inhib-
ited neovascularization in experimental angiogenesis
(Nishimori et al, 1997; Kaur et al, 2005). Recently, C1q-like
proteins, a family of secreted proteins, were found to bind to
BAI3 and to regulate synapse formation and/or maintenance
(Bolliger et al, 2011). CLs and BAIs are now known to be two
of the most mutated genes in human cancers (especially in
squamous lung carcinoma and lung adenocarcinoma) and
may act as tumour suppressor genes (Wood et al, 2007; Jones
et al, 2008; Parsons et al, 2008; Kan et al, 2010). On the other
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1364hand, PKD family proteins are not GPCRs, but they contain
large extracellular sequences, multiple transmembrane re-
gions and a GPS motif similar to cell-adhesion GPCRs
(Ponting et al, 1999). PKD1 is a 500-kDa 11-pass membrane
protein with a large N-terminal extracellular region that is
cleaved at the GPS motif (Qian et al, 2002). It is mutated in
90% of the autosomal dominant PKD (ADPKD) patients
(Rossetti et al, 2001). A mouse mutant with uncleavable
PKD1 exhibits abnormal kidney development (Yu et al, 2007).
In cell-adhesion GPCRs and PKD proteins, the GPS motif is
always located at the end of their long N-terminal extracellular
regions, immediately before the ﬁrst transmembrane helix of the
respective protein (Krasnoperov et al, 1997; Sugita et al, 1998;
Ichtchenko et al,1 9 9 9 ;C h a n get al,2 0 0 3 ;L i net al, 2004;
Figure 1A). The GPS motif is a conserved sequence of B40
amino acids containing canonical cysteine and tryptophan resi-
dues. The GPS is referred to as a ‘domain’ in the Pfam database
although no three-dimensional structure is available, and it is
unclear whether it folds autonomously. Most, if not all, cell-
adhesion GPCRs undergo autoproteolysis in the GPS between a
conserved aliphatic residue (usually a leucine) and a threonine,
serine, or cysteine residue (LkT/S/C) (Krasnoperov et al, 1997,
2002b; Nechiporuk et al, 2001; Lin et al, 2004). Although previous
studies suggested that the GPS motif on its own promotes
autoproteolysis (Krasnoperov et al, 2002a), it is hard to imagine
how such a short sequence could fold into a catalytically active
autoproteolytic domain given the stability of peptide bonds.
Interestingly, in cell-adhesion GPCRs the GPS motif appears to
be preceded by a conserved so-called ‘stalk’ region, which in turn
is often preceded by a Hormone Receptor (HormR) domain, but
the role of these sequences remains unclear.
To shed light on the GPS-mediated autoproteolysis of cell-
adhesion GPCRs and PKD proteins, and to explore the
signiﬁcance of the stalk and GPS sequences and their relation
to the HormR domain, we performed structural and func-
tional studies of fragments containing these regions. Here, we
show that the GPS motif is not an autonomously folded unit
but rather part of a much larger evolutionarily conserved
domain that we refer to as the GPCR-Autoproteolysis
INducing (GAIN) domain. We obtained crystal structures of
fragments from two distantly related cell-adhesion GPCRs
(CL1 and BAI3) that include the GAIN domain and, addition-
ally, the HormR domain. These structures revealed a novel
fold with a high degree of structural conservation of even
distant GAIN domains. Functionally, the entire GAIN domain
is required and sufﬁcient for autoproteolysis. Sequence
analyses showed that the GAIN domain is an ancient domain
that exists in primitive ancestor organisms, and is conserved
in all cell-adhesion GPCRs and all PKD1-related proteins. Our
structures of the cleaved CL1 and uncleaved BAI3 GAIN
domains, in combination with mutagenesis experiments,
reveal the structural determinants for autoproteolysis and
suggest a plausible mechanism of cleavage. Taken together,
our data describe a newly identiﬁed, evolutionarily conserved
domain that is present in 38 different human proteins and
functions as an autoproteolytic fold.
Results
Structures of CL1 and BAI3
To test the signiﬁcance of the sequence arrangements of the
HormR domain, the stalk region and the GPS motif, and to
explore the mechanism of the GPS-mediated autoproteolysis,
we determined the structures of fragments containing these
regions from two distantly related cell-adhesion GPCRs, CL1
and BAI3 (Figure 1A). Experimental phases for the CL1 and
BAI3 structures were independently obtained from sulphur
and iodine single anomalous diffraction (SAD) data at 1.9 and
2.3A ˚ resolution, respectively (Supplementary Table S1,
Materials and methods). Both structures reveal two domains
(Figure 1B and C; Supplementary Figure S1A and B): at the N-
terminus is the smaller B70-residue HormR domain, and at
the C-terminus is a larger B320-residue domain that we refer
to as the GAIN domain; both structures are similar, but with
some signiﬁcant differences (see below and Supplementary
Figure S1C). Surprisingly, the GPS motif is an integral part of
the GAIN domain (comprising the last ﬁve b-strands). Thus,
the GPS motif itself does not constitute an autonomously
folded unit, but rather forms a single folded domain together
with the so-called ‘stalk’.
DALI (Holm and Sander, 1993) searches (as of January
2012) indicated that the GAIN domain is a newly identiﬁed
fold, and that our CL1 and BAI3 crystal structures represent
the ﬁrst high-resolution structures of this domain. The
N-terminal subdomain A of the GAIN domain is composed
of six a-helices, while the C-terminal subdomain B consists
of a twisted b-sandwich including 13 b-strands and 2 small
a-helices. The high similarity of the GAIN domain structures
(root-mean square deviation (r.m.s.d.)¼1.38A ˚; Supple-
mentary Figure S1C) from two distantly related cell-adhesion
GPCRs (24% sequence identity) suggests structural conserva-
tion of this novel domain across the entire family of
cell-adhesion GPCRs.
The GAIN domain functions as an autoproteolytic domain
To determine whether the GAIN domain is the minimally
required region for autoproteolysis, we designed deletion
mutants of full-length CL1: CL1-GPS which lacks the
HormR and GAIN domains except for the GPS motif; CL1-
HormR_GPS in which all residues of the GAIN domain except
for the GPS motif are deleted; CL1-DSubA in which only
subdomain A of the GAIN domain is deleted; and
CL1-DHormR in which only the HormR domain is deleted
(Figure 2A). We expressed the deletion mutants in HEK293
cells, and analysed their autoproteolysis by immunoblotting
of cell lysates, and their plasma membrane transport by
indirect immunoﬂuorescence of non-permeabilized cells.
Our results show that the entire GAIN domain with
both subdomains A and B is required for autoproteolysis
(Figure 2B and C; Supplementary Figure S2A). Consistent
with the identiﬁcation of the GPS motif as an integral part of
the GAIN domain, the GPS motif is not functional by itself
(Figure 2B and C), presumably because it is unfolded when
expressed without the other GAIN domain sequences. A
protein fragment composed of only the GAIN domain of
CL1 underwent autoproteolysis, demonstrating that the
GAIN domain is not only necessary but also sufﬁcient for
autoproteolysis in CL1 (Figures 2D and 5D; Supplementary
Figure S2B). Indeed, the electron density map of the crystal
structure shows that the crystallized HormR-GAIN fragment
of CL1 is cleaved at the expected position (Figure 1D;
Krasnoperov et al, 1997). In addition, the GAIN domain of
GPR56 (a different cell-adhesion GPCR, mutations of which
cause bilateral frontoparietal polymicrogyria (BFPP); Piao
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Supplementary Figure S2C), suggesting that the GAIN do-
main mediates autoproteolysis in other cell-adhesion GPCRs
as well.
The GAIN domain is an ancient conserved fold
To study the evolution of GAIN domains, we searched for the
presence of GAIN domains in the genomes of primitive
evolutionarily distant organisms, and identiﬁed genes encod-
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revealed that the genome of Dictyostelium discoideum,a n
evolutionarily ancient organism that arose before animals
emerged, encodes a GAIN domain (Figure 3A), although it
lacks hedgehog autoproteolytic domains as well as signalling
and adhesion domains found in higher eukaryotes, such as
HormR, Wnt-signalling components, cadherins, immunoglo-
bulins, and integrins (Eichinger et al, 2005). Moreover, a
unicellular ciliate, Tetrahymena thermophila, encodes more
than eight GAIN domains. Thus, the GAIN domain is among
the most ancient GPCR-related extracellular domains.
Computational analysis (McGufﬁn et al, 2000; Pei et al,
2007) of ancient GAIN domain sequences showed that their
predicted secondary structure pattern is identical to that of
the CL1 and BAI3 GAIN domain (Figure 3B; Supplementary
Table S2). Moreover, their GPS motifs including the putative
cleavage sites are well conserved (Figure 3A), whereas those
of the autoproteolytic domain of nucleoporin98 (which also
exists in ciliates) are not. Furthermore, sequence alignments
of cell-adhesion GPCRs and PKD proteins revealed that all
cell-adhesion GPCRs and PKD proteins are predicted to have
a GAIN domain with identical predicted secondary structure
patterns to that of the CL1 and BAI3 crystal structures
(Figure 3B; Supplementary Table S3). Apart from the shared
GAIN domain, PKD proteins are unrelated to cell-adhesion
GPCRs but also undergo autoproteolysis (Ponting et al,
1999), indicating that the GAIN domain has been utilized
by at least two different membrane protein families during
evolution. These results suggest that the GAIN domain
evolved prior to the evolutionary emergence of animals,
that it is one of the ﬁrst functional autoproteolytic domains,
and thus represents an ancient feature that is not directly
connected to multicellularity.
Autoproteolysis does not lead to the dissociation of the
cleavage products
In general, autoproteolysis domains produce two protein frag-
ments that then dissociate (e.g., hedgehog and protein inteins).
Strikingly, the cleaved b-strand in the CL1 structure is well
ordered with full occupancy and thermal factors comparable to
the surrounding protein, indicating no sign of dissociation
(Figure 1D). The cleaved b-strand is tightly bound to the rest
of the GAIN domain involving an extensive network of con-
served interstrand hydrogen bonds and primarily hydrophobic
side-chain interactions (Figure 1Fand G). Thus, we predict that
dissociation of the cleaved b-strand would be energetically
unfavourable, and would conceivably lead to unfolding of the
remaining part of the GAIN domain. Consistent with this
structural prediction, the N-terminal cleavage product of full-
length CL1 and CL3 in transfected HEK293 cells remained
bound to the rest of the protein on the cell surface, and was not
secreted into the media (Figure 1H). Thus, the GAIN domain
forms a tightly associated heterodimer upon proteolysis.
Different from CL1, the electron density of the crystal
structure of the BAI3 GAIN domain showed no evidence of
cleavage (Figure 1E, Supplementary Figure 7B), and BAI3
expressed in transfected HEK293 cells was uncleaved
(Figure 4A). To address the question whether the BAI3
GAIN domain is functional, we raised antibodies to BAI
proteins and showed that endogenous BAI proteins in brain
are cleaved (Figure 4C). The conditions of BAI expression
(i.e., expression levels, glycosylation machinery, and reduc-
tive environment) are very different between insect cells
(used for expression of the crystallized proteins) and
HEK293 cells on the one hand, and neurons on the other
hand. Thus, these differences in post-translational processing
and environment could be the reason why BAI3 is uncleaved
when expressed in insect or HEK293 cells, but cleaved in the
brain. Nevertheless, uncleaved BAI3 was efﬁciently trans-
ported to the plasma membrane in HEK293 cells, indicating
that cleavage at the GPS is not required for surface transport
of a cell-adhesion GPCR (Figure 4B; see also below). In
contrast, autoproteolysis of the autoproteolytic protein nu-
cleoporin98 is required for its transport to the nuclear envel-
ope (Hodel et al, 2002).
Unique structural features of the GAIN domain enable
autoproteolysis
The autocatalytic scissile bond in the GPS of the GAIN
domain (star, Figure 5A and B) is positioned at a sharply
kinked loop between the last two b-strands of the GAIN
domain. In the structure of the uncleaved BAI3 GAIN domain,
the autocatalytic scissile bond (Figure 1E) has a distorted
geometry (phi¼174.0, psi¼ 158.2 degrees). Furthermore,
numerous residues contribute to the unique structural
features of the GAIN domain that localize the scissile bond
at the tip of the sharply kinked loop (Figure 5A and B; Supple-
mentary Figure S3A and B). The kink is created due to three
structural features of the protein: (1) Two conserved disul-
phide bonds (C834-C820 and C832-C801 in CL1) between
neighbouring b-strands (Supplementary Figure S3A) keep
this b-turn in place. (2) The cleaved b-strand has conserved
residues involved in numerous hydrophobic interactions with
other conserved residues (Figure 1F). (3) The side chain of
Figure 1 Structures of CL1 and BAI3. (A). Diagram of CL1 and BAI3 showing the domains suggested by the SMART protein domain prediction
server. No domain is predicted for the stalk region (coloured yellow and light pink). Note that GPS is deﬁned as a separate domain in the Pfam
database (magenta). In contrast, our crystal structures (see B and C) now show that the GPS motif is not an autonomously folded domain, but
rather an integral part of the GAIN domain. The stalk region is also part of the GAIN domain. The HormR, TM7, lectin, olfactomedin, and
thrombospondin motifs are coloured blue, green, cyan, red, and orange, respectively. The boundaries of the crystal structures are indicated with
arrows. (B, C) Cartoon representation of the crystal structure of the HormR and GAIN domains of CL1 (PDB accession code 4DLQ) (B) and BAI3
(PDB accession code 4DLO) (C). The HormR domain is coloured blue, the GAIN subdomain Ayellow, the GAIN subdomain B light pink, and the
GPS motif, which is part of subdomain B, magenta. The cleaved b-strand of CL1 and the corresponding uncleaved b-strand of BAI3 are coloured
orange and cyan, respectively. Disulphide bonds and carbohydrates are shown as black and red sticks, respectively. (D)2 mFo DFc electron
density map of the indicated residues around the cleavage site in CL1, contoured at 2s.( E)2 mFo DFc electron density map of the corresponding
uncleaved site in BAI3, also contoured at 2s.( F) Showing the hydrophobic packing interactions between the cleaved b-strand and the
surrounding residues in CL1. (G) Showing the hydrogen bonds between the cleaved b-strand and the surrounding residues in CL1. In all panels,
the cleavage site in CL1 and the corresponding peptide bond in BAI3 are marked with a black star. (H) The majority of the extracellular regions of
CL1 and CL3 remain attached to the cells upon cleavage. HEK293 cells were transfected with full-length CL1 and CL3 constructs. Equal ratio of
cell lysates and media were loaded on the gel and immunoblotted for the N-terminal Flag epitope. (I) The cleaved b-strand of the GAIN domain
undergoes a conformational change upon autoproteolysis (the direction of the movement is indicated by arrows).
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Figure 2 The GAIN domain is an autoproteolytic domain. (A) Diagram showing the CL1 deletion mutants that we tested in full-length CL1.
The constructs were tagged with Flag and Haemagglutinin A (HA) epitopes (grey), both facing the extracellular side. (B) Effect of domain
deletions on cleavage of CL1 constructs in HEK293 cells. For the cleavage assay, cell extracts were immunoblotted for the HA epitope. If
cleavage at the GPS site occurs, a C-terminal 70kDa fragment is produced. FL represents full length. (C) Effect of the domain deletions on cell-
surface transport of CL1 in HEK293 cells. Transfected HEK293 cells expressing the indicated CL1 proteins were analysed by immunocy-
tochemistry using antibodies to the HA tag; cells were either analysed with or without permeabilization. Cells were visualized by confocal
microscopy using an Alexa-488 secondary antibody. (D) A construct encoding only the GAIN domain of CL1 as an Ig-fusion protein is
autoproteolysed in transfected HEK293 cells whereas the two autoproteolysis site mutants are not cleaved (blotted for Ig). (E) Schematic
domain diagram of GPR56. (F) A construct encoding only the GAIN domain of GPR56 as a myc tagged PDGF receptor transmembrane domain-
fusion protein is autoproteolysed whereas the two autoproteolysis site mutants are not cleaved (blotted for myc-epitope).
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conserved hydrophobic pocket (Supplementary Figure S3B).
Comparison of the cleaved and uncleaved GAIN domain
structures revealed a small tilt of the cleaved b-strand upon
autoproteolysis that relaxes the sharp kink (Figure 1I).
To understand the mechanism of GAIN-domain catalysed
autoproteolysis, we performed extensive mutagenesis of the
CL1 GAIN domain (Figure 5C). Among others, three muta-
tions (H836S, L837A, and T838G) impaired autoproteolysis
but did not interfere with surface transport (and conse-
quently, protein folding) (Figure 5C and D; Supplementary
Figure S4), indicating that these residues are directly involved
in CL1 autoproteolysis (also providing further evidence that
autoproteolysis is not required for trafﬁcking of GAIN
domain-containing proteins). Consistent with a previously
proposed mechanism for GPS autoproteolysis (Lin et al,
2004), H836 may act as a general base (although the general
base is likely different in BAI3 since that residue is an
Arginine; Figure 5A and B). The general base then removes
the hydroxyl hydrogen from the side chain of T838 (Serine in
BAI3) that in turn makes a nucleophilic attack on the
carbonyl carbon of L837 (conserved in both CL1 and BAI3).
Note that the T838P (Krasnoperov et al, 2002b) and T838A
mutants are unfolded (Figure 5D; Supplementary Figure S4),
but replacing threonine with a glycine enables proper folding,
presumably by decreasing rigidity at the cleavage site.
Disease-related mutations in PKD1 and CL GAIN domains
The GAIN domain of PKD1 is a hot spot for mutations
associated with ADPKD, one of the most common monogenic
diseases (1 in 1000) (Qian et al, 2002; Figure 6A). In addition,
CL and BAI genes are among the most frequently mutated
genes in human cancers, with mutation frequencies of 3 and
12%, respectively (Kan et al, 2010). Their GAIN domains are,
again, a hot spot for cancer mutations (Figure 6C;
Supplementary Figure S6A). We tested the ADPKD and
cancer mutations in GAIN domains for their effect on autop-
roteolysis and plasma membrane localization. Almost all
ADPKD mutations in the GAIN domain of PKD1 abolished
autoproteolysis, either by directly interfering with catalysis or
by altering their membrane localization (presumably, by
impairing folding) (Figure 6A and B; Supplementary Figure
S5), indicating an essential role for the GAIN domain.
However, cancer mutations in CL1 and CL3 did not affect
autoproteolysis or membrane localization (Figure 6C and D;
Supplementary Figure S6), suggesting that the mechanism by
which these mutations lead to disease is different from that of
the ADPKD mutations. Since most cancer mutations are
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were checked against the crystal structure of the GAIN domain and only those that had the same pattern were identiﬁed as GAIN domains.
(A) Showing the sequence alignment of GPS motifs from evolutionary ancient organisms (top, Tetrahymena thermohila (gi89298346), Dictyostelium
discoideum (gi66815909), Monosiga brevicollis (gi16752408), Trichoplax adhaerens (gi19600360), Caenorhabditis elegans (gi11553241)), PKD
homologues (middle), and cell-adhesion GPCRs (bottom). The evolutionary relationship between the ancient organisms is described as a tree. The
minimum number of GAIN domains in each organism’s genome is indicated in parenthesis. The conserved cysteines, tryptophans, and cleavage site
residues are highlighted black, magenta, and cyan, respectively. Disease mutations (ADPKD, cancer, and BFPP) are highlighted yellow. The cleavage
site is indicated with an arrow. Disulphide bonds are shown as black lines. (B) Predicted consensus secondary structure pattern for representative
ancient GAIN domains, cell-adhesion GPCRs, and PKD-related proteins shown in Supplementary Tables S2 and S3.
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involved in the interaction of the GAIN domain with a ligand
or with the nearby transmembrane helices. Indeed, it is the
GAIN domain of CL1 that interacts with its long-known
binding partner a-latrotoxin, a black widow spider toxin
(Sudhof, 2001; Figure 7), demonstrating the ability of the
CL1 GAIN domain to function as a protein-binding domain in
addition to an autoproteolytic domain.
Cell-adhesion GPCRs exhibit structural similarity to
hormone receptors
Although the HormR domain is the second most frequently
observed domain in cell-adhesion GPCRs (found in 12 of 33
human cell-adhesion GPCRs), no hormones have yet been
identiﬁed to bind cell-adhesion GPCRs. HormR domain-con-
taining cell-adhesion GPCRs are homologous to Class B
GPCRs that always include a HormR domain (Lagerstrom
and Schioth, 2008). Remarkably, our HormR domain crystal
structures from CL1 and BAI3 revealed an unusually high
structural similarity (0.7A ˚ r.m.s.d.) to the genuine hormone-
binding domain of the corticotrophin releasing factor receptor
(CRFR), a member of the class B GPCRs, supporting the
hypothesis that cell-adhesion GPCRs may be hormone recep-
tors (Figure 8A).
Superposition of the CL1 structure with the structure of the
CRFR HormR domain bound to corticotrophin releasing
factor (CRF), a 41 amino-acid peptide hormone, reveals that
a similar hormone could not bind to CL1 HormR in the
conformation observed in the crystal structure since the
GAIN domain is blocking the homologous hormone binding
site on the HormR domain of CL1 (Figure 8B). Clearly,
hormone binding would require a conformational change in
CL1 to expose the putative hormone binding site. In class B
GPCRs, the HormR domain precedes the transmembrane
helices and is juxtaposed to the membrane. According to
the two-domain model of class B GPCR activation, the inter-
action of the extracellular hormone-binding domain with the
hormone promotes the interaction of the hormone with the
transmembrane helices, leading to the activation of the
receptor (Hoare, 2005). However, the mechanism of
cell-adhesion GPCR activation upon hormone binding may
be different, because the GAIN domain lies between the
HormR domain and the transmembrane helices.
Discussion
In this study, we aimed to obtain a structural understanding
of the autoproteolysis function of the GPS motif that is
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Figure 4 BAI3 GAIN domain is functional but its autoproteolysis is not required for surface transport. (A) Immunoblots of the lysates from
HEK293 cells transfected with BAI1, BAI2, or BAI3 constructs tagged with mVenus in their C-terminal tails. Sample amounts were adjusted for
immunoblotting to obtain comparable signals for BAIs; therefore, unspeciﬁc bands exhibit different intensities (black star). Blots were probed
with antibodies raised against C-terminal epitopes of BAI1 and BAI3. Only full-length (FL) BAIs (200kDa) and N-terminally truncated BAIs of
unknown physiological relevance (FL**) (B170kDa) were detected, but no products of autoproteolytic cleavage (expected mass: B100kDa)
were observed. (B) Images of non-permeabilized HEK293 cells transfected with mVenus-tagged BAI3 cDNA demonstrate cell-surface
membrane localization of uncleaved BAI3 (scale bar¼10 mm). (C) Immunoblots of mouse brain lysates and of brain immunoprecipitates
(IPs) obtained with the BAI1-speciﬁc antibody 11509 (control: IP without 11509) with the antibodies used in (A). AC-terminal cleavage product
of 72kDa was detected.
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proteins. Towards this end, we here determined the crystal
structures of fragments containing the GPS motif, the stalk
region and the HormR domain from two distantly related cell-
adhesion GPCRs, CL1 and BAI3. Unexpectedly, we found that
a single large domain termed the GAIN domain spans the GPS
motif and the stalk region (Figure 1), and that the GPS motif
by itself is not a functional domain, but only a small part of
the much larger GAIN domain. The GAIN domain is a novel
domain, and our CL1 and BAI3 crystal structures now deﬁne
this domain family.
The CL1 deletion experiments showed that the GPS motif
is not functional by itself (Figure 2). Instead the entire GAIN
domain is both required and sufﬁcient for autoproteolysis.
Thus, the GAIN domain functions as an autoproteolytic
fold. Strikingly, structure-based database searches revealed that
primitive organisms, such as Dictyostelium discoideum that
arose early in evolution before animals emerged, encode
GAIN domains although they lack most other autoproteolytic
domains, important adhesion and signalling domains and
critical signalling pathways (Figure 3; Supplementary Table
S2). These ancient GAIN domains have conserved GPS motifs
and are examples of one of the most ancient functional
autoproteolytic domains. Computational analysis of the
GAIN domain sequences showed that all cell-adhesion
GPCRs and all PKD proteins have a GAIN domain with
identical predicted secondary structure patterns to that of
the CL1 and BAI3 crystal structures showing that the GAIN
domain is widespread and conserved in higher eukaryotes as
well as in ancient organisms (Supplementary Table S3). Our
cleaved and uncleaved GAIN domain structures, in combina-
tion with extensive mutagenesis of the CL1 cleavage site,
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Figure 5 Mutagenesis of the CL1 autoproteolysis site. (A) Close-up view of the cleavage site in CL1 (black star). (B) The corresponding site in
uncleaved BAI3 (black star). The colour coding is similar to that in Figure 1, except that the b-strands 12, 13, and the top loop are coloured
green, orange, and grey, respectively. Residues involved in autoproteolysis (see mutagenesis experiments) are highlighted black. Water
molecules and a sulphate ion are shown as red and cyan spheres, respectively. Hydrogen bonds are shown as black dashes. (C) Results of the
cleavage assay of CL1 mutants (same assay as described in Figure 2B). (D) Effect of selected cleavage mutations on cell-surface transport of CL1
in HEK293 cells. Uncleaved, but properly cell-surface localized (i.e., folded), mutants are highlighted black.
Cell-adhesion GPCRs mediates autoproteolysis
D Arac ¸ et al
&2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 6 | 2012 1371reveal the unique structural features of the GAIN domain that
enable self-cleavage and shed light on the mechanism of
autoproteolysis. The discovery of the GAIN domain also
revealed a possible role for the GAIN domain in a variety of
diseases, including cancer, ADPKD, and BFPP. We found that
nearly all ADPKD mutations interfere with autoproteolysis of
the GAIN domain, whereas cancer mutations have no effect
on autoproteolysis or cell-surface localization. Thus, the
mechanism by which the cancer mutations lead to disease
are unrelated to autoproteolysis and the GAIN domain likely
has other functions (such as interacting with ligands or
transmembrane helices) in addition to the autoproteolysis
function.
In summary, our experiments demonstrate that the GAIN
domain is an ancient autoproteolytic domain that exhibits
unique properties and is present in a large number of GPCRs
and PKD proteins. Although the proteolysis of membrane
proteins by sheddases and regulated intramembrane proteo-
lysis (RIP) proteases is well studied (Blobel, 2005; Wang et al,
2006) the autoproteolysis of a membrane protein is poorly
understood. GAIN domain is one of the few domains to
mediate self-cleavage of a membrane protein. Two properties
of the GAIN domain-mediated autoproteolysis make it unique
and intriguing: (1) All GAIN domains that we analysed (from
ancient organisms to higher eukaryotes) always immediately
precede the N-terminal transmembrane helix (Figure 9).
Additionally, HormR domains, when present, always precede
the N-terminus of the GAIN domain. (2) In contrast to most
other autoproteolytic domains that cause the release of the
cleaved mature protein, autoproteolysis of the GAIN domain
does not lead to the dissociation of the cleaved extracellular
sequences containing the GAIN domain from the membrane-
embedded regions of the protein. These observations natu-
rally lead to the hypothesis that the GAIN domain is func-
tionally and/or structurally associated with the membrane
domains and that the GAIN domain-mediated autoproteolysis
has a complex mechanism of action.
The HormR/GAIN/transmembrane helix sequence ar-
rangement is unrelated to the autoproteolysis function of
the GAIN domain although it may be signiﬁcant for the
regulation of receptor signalling via intramolecular interac-
tions. Indeed, deletion of the extracellular sequences of
GPR56, a cell-adhesion GPCR with an extracellular GAIN
domain that is preceded only by a short non-GAIN domain
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Figure 6 The effect of ADPKD and cancer mutations on autoproteolysis. (A) The ADPKD substitution mutations (yellow spheres) and gene
conversion mutations (green spheres) in the human PKD1 gene; and BFPP substitution mutations (red spheres) in the human GPR56 gene are
superposed on the structure of the CL1 GAIN domain. The cleavage site is indicated with a black star. (B) Effect of ADPKD mutations on the
cleavage of the full-length hPKD1 construct that has an N-terminal GFPand a C-terminal Flag tags. HEK293 cells were transfected with the wild-
type and mutant hPKD1 constructs and cell extracts were immunoblotted for the Flag epitope. A C-terminal 130kDa fragment is produced
following autoproteolysis in the GAIN domain. The approximate size of hPKD1 is indicated. The mutants that poorly expressed are labelled
with black stars. (C) The cancer substitution mutations (yellow spheres) in the human CL1 and CL3 genes marked in the structure of the CL1
GAIN domain. (D) Effect of cancer mutations on the cleavage of the full-length rat CL1 and human CL3 that has tags similar to those shown in
Figure 2A. Cell extracts were immunoblotted for the HA epitope. A C-terminal 70kDa fragment is produced following cleavage. FL represents
full length.
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GPCR (Paavola et al, 2011), suggesting a possible inhibitory
role for the GAIN domain. In the GAIN domain, the cleaved
b-strand is separated from the ﬁrst transmembrane helix by
5–6 linker residues (Figure 9), positioning the GAIN and
HormR domains into close proximity to the transmembrane
helices. The small conformational change that we observe
upon autoproteolysis (Figure 1I) may be critical for the
relative orientation of the GAIN domain with respect to the
transmembrane helices. Binding of a hormone to the HormR
domain or binding of an endogenous ligand to the GAIN
domain may be potential regulators of signalling via the
receptor. Our work here redeﬁnes the poorly studied cell-
adhesion GPCR class to share a large unique and widespread
autoproteolytic domain that may be involved in downstream
signalling.
Materials and methods
Protein expression and puriﬁcation
The HormR and GAIN domains of rat CL1 (residues 460–849) and
human BAI3 (residues 498–868) were cloned into the Xba1–Not1
and the BamH1–Not1 sites of the pAcGP67A vector, respectively
(CL1¼43kDa plus 5 carbohydrates; BAI3¼41.7kDa plus 3
carbohydrates). A 8 His tag was added at the C-terminus for
afﬁnity puriﬁcation. Spodoptera frugiperda (Sf9) cells (Invitrogen)
were transfected with pAcGP67A carrying the gene and linearized
AcNPV DNA (Sapphire Baculovirus DNA; Orbigen) using Cellfectin
(Invitrogen). Baculovirus was ampliﬁed in Sf9 cells in 10% (v/v)
fetal bovine serum containing SF900-II medium (Gibco).
Large-scale protein expression of CL1 and BAI3 was performed
by infection of Trichoplusia ni (High Five) cells in Insect-Xpress
medium (Biowhitaker) at a cell density of 2 10
6cells/ml with an
infection course of 72h. The media containing the secreted,
glycosylated, recombinant protein was concentrated and dialysed
using a tangential ﬂow ﬁltration system (PALL) and subsequently
puriﬁed with Ni-NTA resin (Qiagen) at 41C. The proteins were
eluted with 200mM imidazole (pH 7.2). CL1 and BAI3 were further
puriﬁed by size-exclusion chromatography using a Superdex 200
column (Amersham Pharmacia Biotech) in buffer containing 10mM
Hepes (pH 7.2) and 150mM NaCl. The peak corresponding to the
proteins was then concentrated to 10.7mg/ml (for CL1) and 17mg/
ml (for BAI3) in 30kDa Centricon (Millipore) concentrators and
used for crystallization trials.
a-Latrotoxin (residues 413–1080) with N-terminal GSTand Myc tags
in a pGEX-KG vector was expressed in Origami cells. The expression
and puriﬁcation were described in Li et al (2005). The latrotoxin
construct used for native gel experiments corresponds to the 20
ankyrin repeats of latrotoxin with a C-terminal His tag. The protein
was expressed in High Five cells and secreted protein was puriﬁed by
afﬁnity chromatography followed by size-exclusion chromatography.
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Figure 7 The GAIN domain of CL1 binds to a-latrotoxin. (A) Ig-fusion proteins of CL1 comprising the lectin domain (CL1LEC), the GAIN
domain (CL1GAIN), or control (IgC) were expressed in HEK293 cells and puriﬁed on protein A sepharose beads along with Ig-fusion proteins of
Neurexin-1a and Neurexin-1b (N1a and N1b). Recombinant myc–a-latrotoxin produced in bacteria was added. Proteins were visualized by
Coomassie-blue staining (left) or immunoblotting using anti-myc antibody (right). (B) Native gel showing the formation of a complex of CL1-
GAIN domain and the 20 ankyrin repeats of a-latrotoxin in a calcium-independent manner. Both proteins were expressed in insect cells as His-
tagged proteins, secreted to the media, and puriﬁed to 499% purity by afﬁnity tag puriﬁcation followed by size-exclusion chromatography.
Cell-adhesion GPCRs mediates autoproteolysis
D Arac ¸ et al
&2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 6 | 2012 1373The GAIN domain of rat CL1 (residues Thr533–Ile849) was
cloned into a pCMV5 vector and fused to Ig (26kDa) at the
C-terminus and carried an HA tag at the N-terminus. The GAIN
domain of mouse GPR56 (residues Q115–E395) was cloned into the
pDisplay vector with N-terminal HA and C-terminal myc tags and
has the PDGFR single-spanning transmembrane domain at the
C-terminus. The full-length human PKD construct carried
N-terminal GFP and C-terminal Flag tags. Full-length human CL3
was synthesized by codon optimization and carried Flag and HA
tags at identical positions as in CL1.
Crystallization of CL1 and BAI3
Initial screens for crystallization of CL1 were carried out using 96-
well format kits (Hampton Index, Salt and Crystal Screen HT,
Hampton Research) on a Phoenix crystallization robot (Art Robbins
Instruments). Automatic plate scanning by a CrystalPro 2 imaging
system (TriTek Corporation) identiﬁed initial hits in the Wizard 1–2
screen (Emerald Biosystems). After optimization, crystals of CL1
were grown using hanging drop vapour diffusion at 201C in 24-well
format. In all, 1ml of 10.7mg/ml protein in 10mM HEPES pH 7.2,
150mM NaCl was mixed with equal volume of mother liquor
consisting of 1.26M (NH4)2SO4, 0.1M sodium acetate pH 4.5, 0.2M
NaCl, and equilibrated against 1ml mother liquor. Crystals grew to
full size within 3 days. Crystals were cryoprotected by transferring
the crystals into mother liquor with 10, 20, and 28% glycerol
gradually. The best crystals diffracted to dmin¼1.85A ˚. Crystals of
CL1 formed in space group P3121 with one molecule per asymmetric
unit and 67% solvent content.
Crystallization hits for BAI3 were obtained with a 96-well format
kit (Protein Complex, Nextal) at 201C. In all, 17mg/ml protein in
10mM HEPES, 150mM NaCl pH 7.2 was mixed with equal volume
of mother liquor consisting of 15% PEG6000, 0.1M sodium citrate
AB
N
C
HormR
GAIN subdomain A
Hormone
Figure 8 The HormR domains of cell-adhesion GPCRs exhibit structural similarity to genuine hormone-binding domains. (A) Superposition of
the HormR domains of CL1 (blue), BAI3 (grey), and CRFR (green) (PDB ID 3ehu). The structure of the CL1 HormR domain is superposed on the
structure of the CRFR HormR domain (green). (B) Binding of a putative hormone (red a-helix) to the CL1 HormR domain based on hormone
(corticotrophin releasing factor) binding to CRFR would produce a clash with the GAIN domain. Thus, a conformational change would be
required in order to make the putative hormone binding site accessible to the hormone. The colour coding of CL1 is the same as in Figure 1A.
Disulphide bonds are shown as black sticks. The disulphide bond close to the hormone binding site is indicated with a red arrow.
Figure 9 The GAIN and HormR domains are in close proximity to GPCR transmembrane helices. The short linker between the GAIN domain
and the ﬁrst GPCR transmembrane helix brings the GAIN and HormR domains close to the transmembrane domain, restricting possible
arrangements between the domains. A model of CL1 is shown with a plausible arrangement of the GAIN and HormR domains. The model
represents only one of the possible orientations of the GAIN domain with respect to the transmembrane helices. The seven-pass
transmembrane domain (orange) was modelled by homology using the crystal structure of the b2 adrenergic GPCR structure (PDB ID
2RH1) (Cherezov et al, 2007; Rosenbaum et al, 2007), and the GAIN and HormR domains were taken from the crystal structure of CL1. The
cleavage site is indicated with a black star.
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cryoprotected with 25% glycerol. Crystals diffracted to dmin¼2.3A ˚.
Crystals of BAI3 formed in space group C2221 with two molecules
per asymmetric unit and 63% solvent content.
Structure determination and reﬁnement of CL1
For the CL1 structure, experimental phase information was obtained
from sulphur SAD data. This structure was the ﬁrst structure that
was determined at the Stanford Synchrotron Radiation Lightsource
by sulphur SAD phasing using an optimized data collection strategy
for a long wavelength at 2A ˚, and one of a few de-novo structures
that has been determined by sulphur SAD at this resolution. More
than 40 crystals were screened to ﬁnd the best diffracting large
crystal. A test radiation damage experiment was performed on a
different crystal to determine the effect of radiation damage and to
optimize the parameters for the experiment. Three data sets, each
comprising 3601 and offset by 201, were collected on a single long
crystal by translating the beam along the long edge of the crystal.
The crystal was placed in a helium stream operating at 65K to
minimize background scatter at long wavelength and to further
limit radiation damage. Data collection was carried out in inverse
beam mode with a wedge angle of 0.51 and an exposure time of 8s.
Total data collection lasted 9h. The data were collected at a
wavelength of 2A ˚, which limited the resolution to 2.3A ˚ (diffraction
was observed to 1.8A ˚ resolution at a wavelength of 1A ˚). The
resolution limit decreased from 2.3 to 2.7A ˚ at the end of one 3601
data collection as a result of radiation damage. All data sets were
indexed, integrated, scaled, and combined in HKL2000 using the
scale anomalous and high absorption options (Otwinowski, 1997).
The error model was not optimized during scaling. In all, 25
sulphur sites were found (17 sites within the protein and 8 in
sulphate ions from the crystallization condition) by SHELXD
(Schneider and Sheldrick, 2002). SHELXD used a high-resolution
cutoff of 2.7A ˚, at which the I/s was B50. The sulphur sites were
reﬁned using SHARP (Vonrhein et al, 2007). Density modiﬁcation
was performed by DM (Cowtan and Zhang, 1999). Among all space
groups tested, only space group P3121 yielded easily interpretable
electron density maps. The density modiﬁed electron density maps
showed good connectivity of secondary structure elements and
cleavage at the GPS site (Supplementary Figure S7A). The sulphur
sites corresponded to the expected side chains when compared
within the density modiﬁed electron density map. Automatic model
building was done with Phenix Resolve (Terwilliger, 2003) for two
thirds of the structure. The rest of the model building was carried
out manually using Coot (Emsley and Cowtan, 2004), and
reﬁnement performed with Phenix.reﬁne (Adams et al, 2010) using
the MLHL target function with experimental phases. The resulting
model was then reﬁned against the higher resolution native data set
at 1.85A ˚ resolution. The subsequent reﬁnement consisted of
alternating rounds of positional minimization, individual restrained
thermal factor reﬁnement, both using the MLF maximum likelihood
target function, and model building. Water molecules and N-linked
carbohydrates were added. A summary of the data collection and
reﬁnement statistics is given in Supplementary Table S1 (PDB
accession code 4DLQ).
Structure determination and reﬁnement of BAI3
BAI3 crystals were soaked into three solutions containing the
crystallization condition, 0.25M sodium iodide, and 10, 20, and
30% glycerol immediately before they were frozen in liquid
nitrogen. The total soak time was about 1–2min. Only one in ten
crystals survived this treatment. The presence of increased glycerol,
thus viscosity, in the soak solutions prevented the crystals from
cracking. Data collection was done in inverse beam mode with a
wedge angle of 251 and an exposure time of 5.5s. The derivative
crystals were not isomorphous to the native crystals, so the native
data set could not be used for isomorphous phasing. The diffraction
data were collected at a wavelength of 1.6A ˚, resulting in diffraction
data to 2.7A ˚ resolution. Data processing was similar to that of CL1.
The BAI3 structure was independently determined with experi-
mental phases obtained by iodine-SAD data (a density modiﬁed
map of the iodine-SAD data around the GPS site is shown in
Supplementary Figure S7B, clearly indicating lack of cleavage in
contrast to the CL1 structure). SHELXD used a high-resolution
cutoff of 4A ˚, at which the I/s was B50, and it found 6 iodine sites.
There were two molecules in the asymmetric unit and non-
crystallographic symmetry (NCS) restraints were used during initial
reﬁnement cycles using Phenix.reﬁne but were removed at later
stages. A summary of the data collection and reﬁnement statistics is
given in Supplementary Table S1 (PDB accession code 4DLO).
Cleavage and plasma membrane localization experiments
Antibodies. Mouse monoclonal anti-HA antibody was from
Covance and rabbit polyclonal anti-Flag antibody was from Sigma.
Mutagenesis and expression constructs. CL1 deletion constructs
were engineered by PCR oligonucleotide ampliﬁcation. pCMV-CL1
HA Flag was generated as follows: The Flag epitope containing
constructs were obtained by subcloning HindIII–XbaI PCR fragment
from pCMV-CL1 into the same site of pCMV-NL1-Flag. The Flag
epitope was fused at Leu25 of CL1. A single HA epitope was inserted
by PCR between Tyr918 and Glu919 in the second extracellular loop
of CL1. Deletion constructs were generated using pCMV-CL1 HA
Flag construct as a backbone. Deletion constructs are as follow:
pCMV-CL1-DHormR HA Flag was generated by deleting Phe479–
Cys532. pCMV-CL1-GPS HA Flag was generated by deleting
Phe479–Glu792. pCMV-CL1-GPS_HormR HA Flag was generated
by deleting Pro535–Glu792. pCMV-CL1-DSubA HA Flag was
generated by deleting Pro535–Val666. pCMV-IgCL1 LEC was
generated by amplifying Met1–Tyr131 PCR fragment and subcloning
into EcoRI–SalI of pCMV-Ig. pCMV-IgCL1 GAIN was generated by
subcloning the PCR-ampliﬁed fragment of Thr533–Ile849 into SacII–
SalI of pDisplay then by excising EcoRI–SalI fragment and subcloning
into the same sites of pCMV-Ig. Therefore, the resulting pCMV-IgCL1
GAINR construct also bears an N-terminal HA epitope. pCMV IgN1a-1
and pCMVN1b were described elsewhere (Ushkaryov et al, 1994;
Sugita et al, 2001). pCMV-CL1 T838A and pCMV-CL1 T838P were
generated by PCR mutagenesis. PKD mutagenesis was performed by
cutting out the wild-type human PKD with BsiWI restriction enzyme,
pasting the small fragment into a carrier plasmid. After site-directed
mutagenesis was performed, the mutated fragments were subcloned
back into the original plasmid. CL3 and CL1 mutagenesis was
performed by the Qiagen site-directed mutagenesis kit.
Cell culture and transfection. For immunoblotting and immunocy-
tochemistry experiments, HEK293T cells were cultured in 6-well
plates until they reached 70–80% conﬂuency. The cells were then
transfected using 4ml of Fugene 6s (Roche Diagnostics) and 2mgo f
respective CL1 DNA constructs. For immunoblotting experiments,
cells were harvested 48h post transfection. For immunocytochem-
istry experiments, the cells were trypsinized 24h post transfection
and splitted into 12-well plates containing coverslips that have been
previously coated with 0.5mg/ml poly-L-lysine in borate buffer. The
cells were grown on the coverslips for an additional 24h before
further experiments were done. For recombinant Ig-protein expres-
sion, HEK cells were transfected using calcium phosphate with
chloroquine and 20mg of cDNA corresponding to the various Ig
proteins. Media was then harvested 4 days post transfection.
Immunocytochemistry and image acquisition. Cells transfected with
CL1 constructs were washed once with PBS and ﬁxed with 4%
paraformaldehyde for 10min on ice. Cells were washed again three
times with cold PBS and incubated at room temperature for 30min
in a blocking solution containing 3% BSA in PBS with or without
0.1% Triton X-100 meaning that cells were permeabilized or not,
respectively. Mouse anti-HA antibody was then added (1:500 ratio)
and the incubation was prolonged for another 2h. Cells were
washed three times with blocking solution and incubated for 1h at
room temperature with anti-mouse Alexa-488 ﬂuorescent antibody
to label CL1 receptors. Cells were ﬁnally washed again three times
with blocking solution and once with water before mounting on
slides using media containing DaPI for nuclear staining. Slides were
then analysed by confocal microscopy. Images were acquired using
the confocal microscope Leica TCS2. The same confocal acquisition
settings were applied to all samples of the experiment. Collected
z-section images were analysed blindly using Leica confocal software.
Immunoblotting procedures. Transfected HEK cells were harvested
2 days after transfection and solubilized for 1h at 41C in buffer
containing 20mM Hepes-NaOH pH 7.4, 0.1mM EDTA, 150mM
NaCl, 2mM CaCl2, 2mM MgCl2 and 1% Triton. Insoluble material
was removed by centrifugation. SDS–PAGE sample buffer was
added to the supernatant and the resulting sample was loaded on
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membranes and processed using standard procedures. Membranes
were probed with a mouse monoclonal anti-HA antibody or a rabbit
polyclonal anti-Flag antibody followed by Horseradish peroxidase-
coupled secondary antibody, incubated with ECL reagents and
revealed on X-ray ﬁlms.
Ig-fusion protein puriﬁcation and pull-down experiments
The soluble Neurexin and CL1 Ig-fusion proteins were afﬁnity
puriﬁed from transfected HEK293 cell supernatant using protein-A
Sepharose 4 Fast Flow (Amersham Pharmacia Biotech AB, Sweden)
to bind the human-IgG portion and washed to remove unbound
proteins. The immobilized Ig-fusion proteins were then incubated
16h at 41C with the eluted 3mg GST–myc–Latrotoxin in buffer
containing 20mM Hepes buffer, pH 7.4; 0.1mM EDTA, 150mM
NaCl, 2mM CaCl2, 2mM MgCl2 and 1% (v/v) Triton X-100. The
beads were then washed, incubated in boiling SDS–PAGE sample
buffer and loaded on 6% SDS–PAGE. SDS–PAGE gels were either
transferred onto nitrocellulose membrane and immunoblotted with
anti-myc antibody or stained using Coomassie Brilliant Blue R-250
(Bio-Rad).
BAI cleavage experiments
Antibodies. Goat antiserum 11509 and rabbit antisera 233C and
234C were generated against a synthetic peptide (N-CEKAGA
TIPLVGQDIIDLQTEV-C; mouse BAI1). Rabbit antisera A324 and
A323 were raised against recombinant GST-fusion proteins
(P1447-V1582 of mouse BAI1 and R1151-E1348 of human
BAI3, respectively). T3743 was raised against GFP in rabbit.
Cell culture. HEK293Tcells were plated in 6-well plates. At 70–80%
conﬂuency, they were transfected with 1mg expression plasmid
(FuGENE 6 from Roche), and then cultivated for 2 days. Cells were
lysed in extraction buffer (20mM Tris–HCl pH 7.5, 150mM NaCl,
1% Triton X-100, protease inhibitors), homogenized, and the
soluble fractions were collected after centrifugation.
Immunoprecipitation. Two mouse brains were homogenized in
8ml buffer (25mM HEPES pH 7.2, 320mM sucrose, protease
inhibitors). After centrifugation at 1500g for 10min, supernatant S1
was centrifuged at 150000g for 60min. Pellet P2 was then
homogenized in 6ml lysis buffer (50mM Tris–HCl pH 7.5,
100mM NaCl, 1% Triton X-100, protease inhibitors), and centri-
fuged again at 150000g for 60min. In all, 3ml of supernatant S3
was incubated with 18ml antiserum 11509 for 60min. Then, 180ml
protein G sepharose (GE Healthcare) was added, and reactions were
incubated for 3h. The beads were washed four times with lysis
buffer, and the proteins were eluted in SDS buffer.
Immunoblotting. Proteins were resolved on 6% acrylamide gels
and transferred onto nitrocellulose membranes (Whatman). After a
blocking step, membranes were incubated overnight with the
primary antibody diluted in blocking solution (5% milk powder,
2.5% goat or rabbit serum, 0.1% Tween-20, in TBS). After washing
with TBS containing 0.1% Tween-20, blots were incubated with a
peroxidase-conjugated secondary antibody (Cappel) for 45min.
After washing, immunoreactive bands were detected by ECL (GE
Healthcare).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal. org).
Acknowledgements
We thank E O ¨zkan for crystallographic advice and discussion; M
Etherton, X Piao, F Qian for a-latrotoxin, GPR56, and PKD1 cDNAs.
Portions of this research were carried out at the Stanford
Synchrotron Radiation Lightsource, a national user facility operated
by Stanford University on behalf of the US Department of Energy,
Ofﬁce of Basic Energy Sciences. The SSRL Structural Molecular
Biology Program is supported by the Department of Energy, Ofﬁce
of Biological and Environmental Research, and by the National
Institutes of Health, National Center for Research Resources,
Biomedical Technology Program, and the National Institute of
General Medical Sciences. This study was also supported by a
postdoctoral fellowship from Canadian Institutes of Health
Research (CIHR, to AAB) and a grant from the NIMH (R37
MH52804-08 to TCS). D Arac ¸ is a Howard Hughes Medical
Institute Fellow of the Life Sciences Research Foundation.
Author contributions: DA designed and performed experiments
and wrote the paper. AAB, DA, MFB, JN, and MS performed
experiments. TCS and ATB provided guidance and wrote the paper.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
References
Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N,
Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ,
Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS,
Terwilliger TC, Zwart PH (2010) PHENIX: a comprehensive
python-based system for macromolecular structure solution.
Acta Crystallogr D Biol Crystallogr 66: 213–221
Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D,
Domene S, Velez JI, Karkera JD, Balog J, Berg K, Kleta R, Gahl WA,
Roessler E, Long R, Lie J, Pineda D, Londono AC, Palacio JD,
Arbelaez A et al (2010) A common variant of the latrophilin 3 gene,
LPHN3, confers susceptibility to ADHD and predicts effectiveness
of stimulant medication. Mol Psychiatry 15: 1053–1066
Blobel CP (2005) ADAMs: key components in EGFR signalling and
development. Nat Rev Mol Cell Biol 6: 32–43
Bolliger MF, Martinelli DC, Sudhof TC (2011) The cell-adhesion G
protein-coupled receptor BAI3 is a high-afﬁnity receptor for
C1q-like proteins. Proc Natl Acad Sci USA 108: 2534–2539
Chae J, Kim MJ, Goo JH, Collier S, Gubb D, Charlton J, Adler PN,
Park WJ (1999) The Drosophila tissue polarity gene starry night
encodes a member of the protocadherin family. Development 126:
5421–5429
Chang GW, Stacey M, Kwakkenbos MJ, Hamann J, Gordon S, Lin
HH (2003) Proteolytic cleavage of the EMR2 receptor requires
both the extracellular stalk and the GPS motif. FEBS Lett 547:
145–150
Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG,
Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK,
Stevens RC (2007) High-resolution crystal structure of an
engineered human beta2-adrenergic G protein-coupled receptor.
Science 318: 1258–1265
Cowtan KD, Zhang KY (1999) Density modiﬁcation for macromo-
lecular phase improvement. Prog Biophys Mol Biol 72: 245–270
Davies B, Baumann C, Kirchhoff C, Ivell R, Nubbemeyer R,
Habenicht UF, Theuring F, Gottwald U (2004) Targeted deletion
of the epididymal receptor HE6 results in ﬂuid dysregulation and
male infertility. Mol Cell Biol 24: 8642–8648
Deak F, Liu X, Khvotchev M, Li G, Kavalali ET, Sugita S, Sudhof TC
(2009) Alpha-latrotoxin stimulates a novel pathway of Ca2+-
dependent synaptic exocytosis independent of the classical sy-
naptic fusion machinery. J Neurosci 29: 8639–8648
Ebermann I, Wiesen MH, Zrenner E, Lopez I, Pigeon R, Kohl S,
Lowenheim H, Koenekoop RK, Bolz HJ (2009) GPR98
mutations cause Usher syndrome type 2 in males. J Med Genet
46: 277–280
Eichinger L, Pachebat JA, Glockner G, Rajandream MA, Sucgang R,
Berriman M, Song J, Olsen R, Szafranski K, Xu Q, Tunggal B,
Kummerfeld S, Madera M, Konfortov BA, Rivero F, Bankier AT,
Lehmann R, Hamlin N, Davies R, Gaudet P et al (2005) The
genome of the social amoeba Dictyostelium discoideum. Nature
435: 43–57
Emsley P, Cowtan K (2004) Coot: model-building tools for molecu-
lar graphics. Acta Crystallogr D Biol Crystallogr 60: 2126–2132
Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The
G-protein-coupled receptors in the human genome form ﬁve main
Cell-adhesion GPCRs mediates autoproteolysis
D Arac ¸ et al
The EMBO Journal VOL 31 | NO 6 | 2012 &2012 European Molecular Biology Organization 1376families. Phylogenetic analysis, paralogon groups, and
ﬁngerprints. Mol Pharmacol 63: 1256–1272
Hoare SR (2005) Mechanisms of peptide and nonpeptide ligand
binding to class B G-protein-coupled receptors. Drug Discov Today
10: 417–427
Hodel AE, Hodel MR, Grifﬁs ER, Hennig KA, Ratner GA, Xu S,
Powers MA (2002) The three-dimensional structure of the
autoproteolytic, nuclear pore-targeting domain of the human
nucleoporin Nup98. Mol Cell 10: 347–358
Holm L, Sander C (1993) Protein structure comparison by alignment
of distance matrices. J Mol Biol 233: 123–138
Hughes J, Ward CJ, Aspinwall R, Butler R, Harris PC (1999)
Identiﬁcation of a human homologue of the sea urchin receptor
for egg jelly: a polycystic kidney disease-like protein. Hum Mol
Genet 8: 543–549
Ichtchenko K, Bittner MA, Krasnoperov V, Little AR, Chepurny O,
Holz RW, Petrenko AG (1999) A novel ubiquitously expressed
alpha-latrotoxin receptor is a member of the CIRL family of
G-protein-coupled receptors. J Biol Chem 274: 5491–5498
Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P,
Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B,
Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T,
Nikolsky Y, Hartigan J, Smith DR et al (2008) Core signalling
pathways in human pancreatic cancers revealed by global
genomic analyses. Science 321: 1801–1806
Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM,
Y u eP ,H a v e r t yP M ,B o u r g o nR ,Z h e n gJ ,M o o r h e a dM ,C h a u d h u r iS ,
T o m s h oL P ,P e t e r sB A ,P u j a r aK ,C o r d e sS ,D a v i sD P ,C a r l t o nV E ,
Yuan W, Li L et al (2010) Diverse somatic mutation patterns and
pathway alterations in human cancers. Nature 466: 869–873
Kaur B, Brat DJ, Devi NS, Van Meir EG (2005) Vasculostatin, a
proteolytic fragment of brain angiogenesis inhibitor 1, is an anti-
angiogenic and antitumorigenic factor. Oncogene 24: 3632–3642
Krasnoperov V, Bittner MA, Mo W, Buryanovsky L, Neubert TA,
Holz RW, Ichtchenko K, Petrenko AG (2002a) Protein-tyrosine
phosphatase-sigma is a novel member of the functional family of
alpha-latrotoxin receptors. J Biol Chem 277: 35887–35895
Krasnoperov V, Lu Y, Buryanovsky L, Neubert TA, Ichtchenko K,
Petrenko AG (2002b) Post-translational proteolytic processing of
the calcium-independent receptor of alpha-latrotoxin (CIRL), a
natural chimera of the cell adhesion protein and the G protein-
coupled receptor. Role of the G protein-coupled receptor proteo-
lysis site (GPS) motif. J Biol Chem 277: 46518–46526
Krasnoperov VG, Bittner MA, Beavis R, Kuang Y, Salnikow KV,
Chepurny OG, Little AR, Plotnikov AN, Wu D, Holz RW,
Petrenko AG (1997) alpha-Latrotoxin stimulates exocytosis by
the interaction with a neuronal G-protein-coupled receptor.
Neuron 18: 925–937
Kuhnert F, Mancuso MR, Shamloo A, Wang HT, Choksi V, Florek M,
Su H, Fruttiger M, Young WL, Heilshorn SC, Kuo CJ (2010)
Essential regulation of CNS angiogenesis by the orphan G pro-
tein-coupled receptor GPR124. Science 330: 985–989
Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-
coupled receptors and signiﬁcance for drug discovery. Nat Rev
Drug Discov 7: 339–357
Langenhan T, Promel S, Mestek L, Esmaeili B, Waller-Evans H,
Hennig C, Kohara Y, Avery L, Vakonakis I, Schnabel R, Russ AP
(2009) Latrophilin signaling links anterior-posterior tissue
polarity and oriented cell divisions in the C. elegans embryo.
Dev Cell 17: 494–504
Lee JJ, Ekker SC, von Kessler DP, Porter JA, Sun BI, Beachy PA
(1994) Autoproteolysis in hedgehog protein biogenesis. Science
266: 1528–1537
Lelianova VG, Davletov BA, Sterling A, Rahman MA, Grishin EV,
Totty NF, Ushkaryov YA (1997) Alpha-latrotoxin receptor,
latrophilin, is a novel member of the secretin family of G
protein-coupled receptors. J Biol Chem 272: 21504–21508
Li G, Lee D, Wang L, Khvotchev M, Chiew SK, Arunachalam L,
Collins T, Feng ZP, Sugita S (2005) N-terminal insertion and
C-terminal ankyrin-like repeats of alpha-latrotoxin are critical
for Ca2+-dependent exocytosis. J Neurosci 25: 10188–10197
Lin HH, Chang GW, Davies JQ, Stacey M, Harris J, Gordon S (2004)
Autocatalytic cleavage of the EMR2 receptor occurs at a con-
served G protein-coupled receptor proteolytic site motif. J Biol
Chem 279: 31823–31832
McGufﬁn LJ, Bryson K, Jones DT (2000) The PSIPRED protein
structure prediction server. Bioinformatics 16: 404–405
Monk KR, Naylor SG, Glenn TD, Mercurio S, Perlin JR, Dominguez
C, Moens CB, Talbot WS (2009) A G protein-coupled receptor is
essential for Schwann cells to initiate myelination. Science 325:
1402–1405
Nechiporuk T, Urness LD, Keating MT (2001) ETL, a novel
seven-transmembrane receptor that is developmentally regulated
in the heart. ETL is a member of the secretin family and belongs
to the epidermal growth factor-seven-transmembrane subfamily.
J Biol Chem 276: 4150–4157
Nishimori H, Shiratsuchi T, Urano T, Kimura Y, Kiyono K, Tatsumi
K, Yoshida S, Ono M, Kuwano M, Nakamura Y, Tokino T (1997) A
novel brain-speciﬁc p53-target gene, BAI1, containing thrombos-
pondin type 1 repeats inhibits experimental angiogenesis.
Oncogene 15: 2145–2150
Otwinowski ZMW (1997) Processing of X-ray diffraction data
collected in oscillation mode. Methods Enzymol 276: 307–326
Paavola KJ, Stephenson JR, Ritter SL, Alter SP, Hall RA (2011) The
GPR56 N-terminus controls receptor signaling activity. J Biol
Chem 286: 28914–28921
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P,
Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R,
Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA,
Tekleab H, Diaz Jr LA, Hartigan J et al (2008) An integrated
genomic analysis of human glioblastoma multiforme. Science
321: 1807–1812
Pei J, Kim BH, Tang M, Grishin NV (2007) PROMALS web server for
accurate multiple protein sequence alignments. Nucleic Acids Res
35: W649–W652
Perler FB, Xu MQ, Paulus H (1997) Protein splicing and autopro-
teolysis mechanisms. Curr Opin Chem Biol 1: 292–299
Piao X, Hill RS, Bodell A, Chang BS, Basel-Vanagaite L, Straussberg
R, Dobyns WB, Qasrawi B, Winter RM, Innes AM, Voit T,
Ross ME, Michaud JL, Descarie JC, Barkovich AJ, Walsh CA
(2004) G protein-coupled receptor-dependent development of
human frontal cortex. Science 303: 2033–2036
Ponting CP, Hofmann K, Bork P (1999) A latrophilin/CL-1-like GPS
domain in polycystin-1. Curr Biol 9: R585–R588
Qian F, Boletta A, Bhunia AK, Xu H, Liu L, Ahrabi AK, Watnick TJ,
Zhou F, Germino GG (2002) Cleavage of polycystin-1 requires the
receptor for egg jelly domain and is disrupted by human
autosomal-dominant polycystic kidney disease 1-associated
mutations. Proc Natl Acad Sci USA 99: 16981–16986
Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG,
Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC,
Kobilka BK (2007) GPCR engineering yields high-resolution
structural insights into beta2-adrenergic receptor function.
Science 318: 1266–1273
Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, Roy
S, Bakkaloglu A, Komel R, Winearls CG, Harris PC (2001)
Mutation analysis of the entire PKD1 gene: genetic and diagnostic
implications. Am J Hum Genet 68: 46–63
Schneider TR, Sheldrick GM (2002) Substructure solution with
SHELXD. Acta Crystallogr D Biol Crystallogr 58: 1772–1779
Shima Y, Kengaku M, Hirano T, Takeichi M, Uemura T (2004)
Regulation of dendritic maintenance and growth by a mammalian
7-pass transmembrane cadherin. Dev Cell 7: 205–216
Sudhof TC (2001) alpha-Latrotoxin and its receptors: neurexins and
CIRL/latrophilins. Annu Rev Neurosci 24: 933–962
Sugita S, Ichtchenko K, Khvotchev M, Sudhof TC (1998) alpha-
Latrotoxin receptor CIRL/latrophilin 1 (CL1) deﬁnes an unusual
family of ubiquitous G-protein-linked receptors. G-protein cou-
pling not required for triggering exocytosis. J Biol Chem 273:
32715–32724
Sugita S, Khvochtev M, Sudhof TC (1999) Neurexins are functional
alpha-latrotoxin receptors. Neuron 22: 489–496
Sugita S, Saito F, Tang J, Satz J, Campbell K, Sudhof TC (2001) A
stoichiometric complex of neurexins and dystroglycan in brain.
J Cell Biol 154: 435–445
Terwilliger TC (2003) Automated main-chain model building by
template matching and iterative fragment extension. Acta
Crystallogr D Biol Crystallogr 59: 38–44
Ushkaryov YA, Hata Y, Ichtchenko K, Moomaw C, Afendis S,
Slaughter CA, Sudhof TC (1994) Conserved domain structure of
beta-neurexins. Unusual cleaved signal sequences in receptor-like
neuronal cell-surface proteins. J Biol Chem 269: 11987–11992
Usui T, Shima Y, Shimada Y, Hirano S, Burgess RW, Schwarz TL,
Takeichi M, Uemura T (1999) Flamingo, a seven-pass transmem-
Cell-adhesion GPCRs mediates autoproteolysis
D Arac ¸ et al
&2012 European Molecular Biology Organization The EMBO Journal VOL 31 | NO 6 | 2012 1377brane cadherin, regulates planar cell polarity under the control of
Frizzled. Cell 98: 585–595
Vonrhein C, Blanc E, Roversi P, Bricogne G (2007) Automated
structure solution with autoSHARP. Methods Mol Biol 364: 215–230
Wang Y, Zhang Y, Ha Y (2006) Crystal structure of a rhomboid
family intramembrane protease. Nature 444: 179–180
Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D,
Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z,
Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA,
Kaminker JS, Zhang Z et al (2007) The genomic landscapes of
human breast and colorectal cancers. Science 318: 1108–1113
Yona S, Lin HH, Siu WO, Gordon S, Stacey M (2008) Adhesion-
GPCRs: emerging roles for novel receptors. Trends Biochem Sci
33: 491–500
Yu S, Hackmann K, Gao J, He X, Piontek K, Garcia-Gonzalez MA,
Menezes LF, Xu H, Germino GG, Zuo J, Qian F (2007) Essential
role of cleavage of Polycystin-1 at G protein-coupled receptor
proteolytic site for kidney tubular structure. Proc Natl Acad Sci
USA 104: 18688–18693
The EMBO Journal is published by Nature
Publishing Group on behalf of European
Molecular Biology Organization. This work is licensed
under a Creative Commons Attribution-Noncommercial-
Share Alike 3.0 Unported License. [http://creativecommons.
org/licenses/by-nc-sa/3.0/]
Cell-adhesion GPCRs mediates autoproteolysis
D Arac ¸ et al
The EMBO Journal VOL 31 | NO 6 | 2012 &2012 European Molecular Biology Organization 1378